Literature DB >> 17178441

Use of quantitative real-time PCR to monitor the shedding and treatment of chlamydiae in the koala (Phascolarctos cinereus).

Bryan Markey1, Charles Wan, Jon Hanger, Che Phillips, Peter Timms.   

Abstract

The aim of this study was to monitor chlamydial shedding patterns in clinically affected koalas before, during and following treatment using quantitative real-time PCR. Swab samples were obtained from 14 koalas presented for treatment at the Australian Wildlife Hospital. Four of these animals were followed over a period of 8-9 weeks. Primers were designed based on the consensus signature sequence of the 16S rRNA chlamydial gene. Additional primers were designed based on the sequence of the koala beta-actin gene and used to normalize chlamydial values when comparing results from different swab samples. Chlamydial 16S rRNA gene copy number was highest in swab samples from clinically affected sites. Daily injections of chloramphenicol resulted in a marked and rapid reduction in the numbers of chlamydiae being shed from all sites. In general, chlamydial copy number was no longer detectable by the end of the 2nd week of treatment. No evidence of relapse of infection was detected at 2 weeks after the cessation of treatment. In contrast, topical chloramphenicol treatment of the eyes required a longer treatment period and had little effect on the shedding of chlamydiae from other sites of the body. Further studies are required to confirm the efficacy of a shorter treatment period.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178441     DOI: 10.1016/j.vetmic.2006.11.022

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

1.  Rapid identification of mycobacteria and drug-resistant Mycobacterium tuberculosis by use of a single multiplex PCR and DNA sequencing.

Authors:  Ailyn C Pérez-Osorio; David S Boyle; Zachary K Ingham; Alla Ostash; Romesh K Gautom; Craig Colombel; Yolanda Houze; Brandon T Leader
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  Expression profiles of the immune genes CD4, CD8β, IFNγ, IL-4, IL-6 and IL-10 in mitogen-stimulated koala lymphocytes (Phascolarctos cinereus) by qRT-PCR.

Authors:  Iona E Maher; Joanna E Griffith; Quintin Lau; Thomas Reeves; Damien P Higgins
Journal:  PeerJ       Date:  2014-03-04       Impact factor: 2.984

3.  Chlamydia Serine Protease Inhibitor, targeting HtrA, as a New Treatment for Koala Chlamydia infection.

Authors:  Amba Lawrence; Tamieka Fraser; Amber Gillett; Joel D A Tyndall; Peter Timms; Adam Polkinghorne; Wilhelmina M Huston
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

4.  Evaluation of reference genes for gene expression in red-tailed phascogale (Phascogale calura) liver, lung, small intestine and spleen.

Authors:  Oselyne T W Ong; Lauren J Young; Julie M Old
Journal:  PeerJ       Date:  2016-10-13       Impact factor: 2.984

5.  Infection with koala retrovirus subgroup B (KoRV-B), but not KoRV-A, is associated with chlamydial disease in free-ranging koalas (Phascolarctos cinereus).

Authors:  Courtney A Waugh; Jonathan Hanger; Joanne Loader; Andrew King; Matthew Hobbs; Rebecca Johnson; Peter Timms
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

6.  Variation in the microbiome of the urogenital tract of Chlamydia-free female koalas (Phascolarctos cinereus) with and without 'wet bottom'.

Authors:  Alistair R Legione; Jemima Amery-Gale; Michael Lynch; Leesa Haynes; James R Gilkerson; Fiona M Sansom; Joanne M Devlin
Journal:  PLoS One       Date:  2018-03-26       Impact factor: 3.240

7.  Optimising the short and long-term clinical outcomes for koalas (Phascolarctos cinereus) during treatment for chlamydial infection and disease.

Authors:  Amy Robbins; Joanne Loader; Peter Timms; Jonathan Hanger
Journal:  PLoS One       Date:  2018-12-27       Impact factor: 3.240

8.  Clinical comparison of five anti-chlamydial antibiotics in koalas (Phascolarctos cinereus).

Authors:  Rosemary Booth; Sharon Nyari
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.